Skip to main content

Table 1 Clinical and social demographic features of patients with and without exacerbation

From: Asthma exacerbations in a subtropical area and the role of respiratory viruses: a cross-sectional study

 

G1 (92)

G2 (61)

 

N (%)

N (%)

P

Male gender

56 (60.9)

42 (68.9)

0.20

White ethnicity

62 (67.4)

28 (45.9)

< 0.01

Monthly family income ≤200 US$

41 (44.6)

39 (63.9)

0.01

Maternal schooling level ≤ 8 years

47 (51.1)

25 (41.0)

0.14

≥ 3 emergency room visits in the past 12 months

73 (76.0)

23 (24.0)

< 0.01

1 or more hospitalisations for asthma in the past 12 months

58 (80.6)

14 (19.4)

< 0.01

Cough or dyspnoea on exertion (yes)

66 (75.0)

22 (25.0)

< 0.01

Nocturnal cough, in-between exacerbations (yes)

70 (80.5)

17 (19.5)

< 0.01

Use of ICS (yes)

6 (19.2)

84 (91.4)

< 0.01

Exposure to furry animals (yes)

58 (65.9)

30 (34.1)

0.09

Exposure to mould (yes)

44 (71.0)

18 (29.0)

0.02

Exposure to house dust mite (yes)

66 (59.5)

45 (40.5)

0.80

Exposure to second hand tobacco smoking (yes)

33 (56.9)

25 (43.1)

0.61

  1. G1 group 1(exacerbated asthmatics), G2 group 2 (non-exacerbated asthmatics), ICS inhaled corticosteroids